In the specific context of KRAS mutant lung cancer, aberrant KRAS signaling drives metabolic rewiring, promoting aerobic glycolysis (the Warburg effect), glutamine addiction, and altered lipid metabolism to fuel tumor progression. This evidence concerns the gene KRAS and neoplasm.